Humacyte, JDRF Collaborating to Develop Insulin-Producing Biovascular Pancreas to Treat Type 1 Diabetes

NEW YORK, N.Y. and DURHAM, N.C., April 27, 2023 -- Humacyte, Inc. , a biotechnology company pioneering the development and manufacturing of off-the-shelf, universally implantable bioengineered... | April 27, 2023

Related Keywords

United States ,Ukraine ,Joyce Allaire ,Esther Latres ,Globenewswire Inc ,Fresenius Medical Care ,Nasdaq ,Humacyte Inc ,Facebook ,Instagram ,Lifesci Advisors ,Drug Administration ,Biovascular Pancreas ,Human Acellular Vessel ,Human Acellular Vessels ,Medicine Advanced Therapy ,Annual Report ,Investor Contact ,Media Contact ,Humacyte ,Nc Stock Exchange ,News ,Information ,Press Release ,Few ,End ,Pril ,023 ,Biotechnology ,Company ,Ioneering ,The ,Development ,Manufacturing ,F ,Universally ,Mplantable Huma Us44486q1031 ,